Marvel Biosciences Corp. (MBCOF)
OTCMKTS · Delayed Price · Currency is USD
0.1107
0.00 (0.00%)
Feb 12, 2026, 9:30 AM EST
Marvel Biosciences Market Cap
Marvel Biosciences has a market cap or net worth of $6.4 million as of February 12, 2026. Its market cap has increased by 28.43% in one year.
Market Cap
6.40M
Enterprise Value
7.64M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.11
Market Cap Chart
Since July 13, 2021, Marvel Biosciences's market cap has decreased from 10.15M to 6.40M, a decrease of -36.94%. That is a compound annual growth rate of -9.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 6.40M | 12.11% |
| Dec 31, 2025 | 5.71M | 7.93% |
| Dec 31, 2024 | 5.29M | 119.55% |
| Dec 29, 2023 | 2.41M | -34.41% |
| Dec 30, 2022 | 3.67M | -46.60% |
| Dec 30, 2021 | 6.88M | -32.23% |
| Jul 13, 2021 | 10.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zenith Capital | 7.99M |
| Curative Biotechnology | 7.94M |
| NKGen Biotech | 7.84M |
| Synlogic | 7.25M |
| LakeShore Biopharma | 6.63M |
| BetterLife Pharma | 6.49M |
| Brainstorm Cell Therapeutics | 6.37M |
| Orgenesis | 5.90M |